SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001100412-19-000020
Filing Date
2019-05-07
Accepted
2019-05-07 08:12:34
Documents
4
Period of Report
2019-05-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8k_572019.htm 8-K 31259
2 EXHIBIT 99.1 earningspressrelease3q19_d.htm EX-99.1 83164
3 earningspressrelease3_image1.gif GRAPHIC 7061
4 earningspressrelease3_image2.gif GRAPHIC 215529
  Complete submission text file 0001100412-19-000020.txt   422337
Mailing Address 3200 WALNUT STREET BOULDER CO 80301
Business Address 3200 WALNUT STREET BOULDER CO 80301 3033816600
ARRAY BIOPHARMA INC (Filer) CIK: 0001100412 (see all company filings)

IRS No.: 841460811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-16633 | Film No.: 19801344
SIC: 2834 Pharmaceutical Preparations